Skip to main content
Fig. 1 | BMC Pulmonary Medicine

Fig. 1

From: Economic burden of locoregional and metastatic relapses in resectable early-stage non-small cell lung cancer in Spain

Fig. 1

Local treatments in locoregional relapse. a shows the different local treatments grouped into surgery, radiotherapy, and chemotherapy, while 1b shows the distribution of these local treatments without grouping. *Adjuvant chemotherapy: 9% platinum + gemcitabine, 13% platinum + pemetrexed, 70% platinum + vinorelbine, 8% platinum + paclitaxel. **Chemo-radiotherapy: 38% platinum + vinorelbine, 31% platinum + paclitaxel, 31% platinum + etoposide

Back to article page